Immunovia AB (publ) 0G8X.L Stock
1.4 SEK
{{ price }}
-4.632158%
{{change_pct}}%
COUNTRY
United Kingdom
Exchange
LSE
Market Cap
270.38K SEK
LOW - HIGH [24H]
0.0000
-
0.0000 SEK
VOLUME [24H]
0 SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-7.805 SEK
Immunovia AB (publ) Price Chart
Immunovia AB (publ) 0G8X.L Financial and Trading Overview
| Immunovia AB (publ) stock price | 1.4 SEK |
| Previous Close | 2.01 SEK |
| Open | 0 SEK |
| Bid | 0 SEK x 0 |
| Ask | 0 SEK x 0 |
| Day's Range | 0 - 0 SEK |
| 52 Week Range | 0 - 42.48 SEK |
| Volume | 17K SEK |
| Avg. Volume | 4.24K SEK |
| Market Cap | 383.94K SEK |
| Beta (5Y Monthly) | 1.560919 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.805 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0G8X.L Valuation Measures
| Enterprise Value | 12.69M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.25889683 |
| Price/Book (mrq) | 0.23159368 |
| Enterprise Value/Revenue | 8.557 |
| Enterprise Value/EBITDA | -0.068 |
Trading Information
Immunovia AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.560919 |
| 52-Week Change | -95.32% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 42.48 SEK |
| 52 Week Low | 0 SEK |
| 50-Day Moving Average | 8.35 SEK |
| 200-Day Moving Average | 22.77 SEK |
0G8X.L Share Statistics
| Avg. Volume (3 month) | 4.24K SEK |
| Avg. Daily Volume (10-Days) | 4.66K SEK |
| Shares Outstanding | 19.53M |
| Float | 19.32M |
| Short Ratio | N/A |
| % Held by Insiders | 15.65% |
| % Held by Institutions | 1.56% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -13012.94% |
| Gross Margin | -169.58% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.33% |
| Return on Equity (ttm) | -60.42% |
Income Statement
| Revenue (ttm) | 1.48M SEK |
| Revenue Per Share (ttm) | 0.07 SEK |
| Quarterly Revenue Growth (yoy) | 185.69% |
| Gross Profit (ttm) | -3066000 SEK |
| EBITDA | -187064992 SEK |
| Net Income Avi to Common (ttm) | -175638000 SEK |
| Diluted EPS (ttm) | -7.805 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 68.24M SEK |
| Total Cash Per Share (mrq) | 3.02 SEK |
| Total Debt (mrq) | 35.94M SEK |
| Total Debt/Equity (mrq) | 18.5 SEK |
| Current Ratio (mrq) | 2.667 |
| Book Value Per Share (mrq) | 8.584 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -169204992 SEK |
| Levered Free Cash Flow (ttm) | -99943504 SEK |
Profile of Immunovia AB (publ)
| Country | United Kingdom |
| State | N/A |
| City | Lund |
| Address | Medicon Village |
| ZIP | 223 63 |
| Phone | 46 4 62 75 60 00 |
| Website | https://www.immunovia.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 51 |
Immunovia AB (publ), a diagnostic company, develops and commercializes blood-based diagnostics for cancer in Sweden and internationally. It offers IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Q&A For Immunovia AB (publ) Stock
What is a current 0G8X.L stock price?
Immunovia AB (publ) 0G8X.L stock price today per share is 1.4 SEK.
How to purchase Immunovia AB (publ) stock?
You can buy 0G8X.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immunovia AB (publ)?
The stock symbol or ticker of Immunovia AB (publ) is 0G8X.L.
How many shares does Immunovia AB (publ) have in circulation?
The max supply of Immunovia AB (publ) shares is 193.13K.
What is Immunovia AB (publ) Price to Earnings Ratio (PE Ratio)?
Immunovia AB (publ) PE Ratio is now.
What was Immunovia AB (publ) earnings per share over the trailing 12 months (TTM)?
Immunovia AB (publ) EPS is -7.805 SEK over the trailing 12 months.